Sort
38,696 grants matching “als”
Alcohol Use Trajectories and Prevention: A US-Sweden Comparison
$451,251Mary E Larimer · University Of Washington · R01 · FY2014 · AA
Novel Antimicrobial Agents Against M. tuberculosis
$451,198Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2006 · AI
Traumatic Stress and Alcohol Problems: Between- and Within- Person Associations
$451,172Jeffrey S Simons · University Of South Dakota · R01 · FY2012 · AA
C9ORF72 in Motor System Biology and ALS
$451,171Kevin C Eggan · Harvard University · R01 · FY2016 · NS
Identification of genetic features of delay discounting using a heterogeneous stock rat model
$451,072Suzanne H Mitchell · Oregon Health & Science University · U01 · FY2022 · DA
Modifiers of C9orf72 repeat dynamics
$451,045Vanessa C Wheeler · Massachusetts General Hospital · R21 · FY2019 · NS
Cell therapy using neurodegenerative disease modifying molecules (NDMMs) as a means to modulate oxidative damage and neuronal survival in ALS
$451,000Charles L Sentman · Dartmouth College · R21 · FY2020 · NS
Deep Behavioral Phenotyping of Novel Zebrafish Epilepsy Models
$451,000Scott Charles Baraban · University Of California, San Francisco · R21 · FY2024 · NS
Modifying intrinsic growth capacity through axonal mRNA translation
$450,999Jeffery L Twiss · University Of South Carolina At Columbia · R01 · FY2016 · NS
Causal Pathways to population health impact of HIV antiretroviral treatment
$450,979Frank Courteney Tanser · Kwazulu-Natal Research Institute Tb-Hiv · R01 · FY2021 · HD
Causal Pathways to population health impact of HIV antiretroviral treatment
$450,979Frank Courteney Tanser · Kwazulu-Natal Research Institute Tb-Hiv · R01 · FY2019 · HD
Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading
$450,959Xiaobo Mao · Johns Hopkins University · R01 · FY2022 · AG
Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading
$450,959Xiaobo Mao · Johns Hopkins University · R01 · FY2023 · AG
Heterochronic Blood Exchange Inhibits α?Synucleinopathy through Modulating Plasma Protein's Mediation on Pathological α?Synuclein Spreading
$450,959Xiaobo Mao · Johns Hopkins University · R01 · FY2024 · AG
Novel Antimicrobial Agents Against M. tuberculosis
$450,927Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2007 · AI
Defining immune cell heterogeneity in human ALS and mouse model of the disease
$450,923Serge E Przedborski · Columbia University Health Sciences · R01 · FY2021 · NS
PET Imaging of Cortical Dopamine Transmission in Cocaine Addiction
$450,917Rajesh Narendran · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DA
Synergistic Studies of Raindrop Shapes, Oscillations and Orientations Using 2D-Video Disdrometer, Advanced Radar and Wind Tunnel
$450,846Viswanathan N Bringi · Colorado State University · · FY2009 · GEO
Causal Pathways to population health impact of HIV antiretroviral treatment
$450,829Frank Courteney Tanser · Kwazulu-Natal Research Institute Tb-Hiv · R01 · FY2017 · HD
Research Strategy: Multisystemic Study of Early Mathematics Development
$450,823David C Geary · University Of Missouri-Columbia · P20 · FY2022 · HD
To Combine CRISPR/Cas9 Genome Editing, Nanotech and Chemical Genetics toward in vivo Protein Kinase Analysis
$450,806Degeng Wang · Texas Tech University · R15 · FY2017 · GM
Synthesis of bone-selective osteogenic oxysterols
$450,621Frank Stappenbeck · Max Biopharma, Inc. · R44 · FY2017 · AR
Using motor neuron specific miRNA to understand and develop novel therapeutics for motor neuron disease
$450,601Timothy M. Miller · Washington University · R01 · FY2018 · NS
Growth Factors in Lung Development
$450,586Saverio Bellusci · Children'S Hospital Of Los Angeles · R01 · FY2012 · HL
Core--Mechanisms and Measures
$450,579William Gerin · Columbia University Health Sciences · R24 · FY2007 · HL